Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 04, 2015 12:50 AM ET

Biotechnology

Company Overview of Biovest International Inc.

Company Overview

Biovest International, Inc., a biotechnology company, develops therapeutic cancer vaccines in the United States. It operates in two segments, Instrumentation and Vaccine. The company develops and commercializes BiovaxID, a personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. It is also involved in the development, commercialization, manufacture, and sale of instruments and disposables, including AutovaxID, an automated cell culture system that enables production of personalized cell-based treatments; HF Primer, a cell culture system for producing small quantities of the cell culture products from mammalian cell lines; and Multi-6, a cell culture system for produ...

300 South Hyde Park Avenue

Suite 210

Tampa, FL 33606

United States

Founded in 1981

41 Employees

Phone:

813-864-2554

Fax:

813-258-6912

Key Executives for Biovest International Inc.

Chief Executive Officer and President
Age: 37
Executive Chairman and Member of Compensation Committee
Age: 67
Chief Medical Officer
Director of Legal Affairs and Corporate Secretary
Compensation as of Fiscal Year 2014.

Biovest International Inc. Key Developments

Biovest International Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 11:45 AM

Biovest International Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 11:45 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Biovest International Inc. Presents at The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum, Mar-19-2014 02:15 PM

Biovest International Inc. Presents at The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum, Mar-19-2014 02:15 PM. Venue: New York Academy of Sciences, New York, United States.

Biovest International Inc. Announces Executive Changes

Effective December 1, 2013, Biovest International Inc. hired Robert Farrell as Chief Financial Officer of the company. Prior to Mr. Farrell’s hiring, Brian Bottjer had been serving as acting Chief Financial Officer and Controller of the company. Mr. Bottjer will continue to serve as Controller of the company. Before Mr. Farrell’s appointment as Chief Financial Officer of the company, he served as Chief Financial Officer of Sanovas Inc., from 2012 to 2013. Mr. Farrell is a Member of the California Bar.

Similar Private Companies By Industry

Company Name Region
ImmuMed, Inc. United States
Aries Scientific, Inc. United States
Sun BioPharma, Inc. United States
Scantibodies Laboratory, Inc. United States
PluroGen Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Biovest International Inc., please visit www.biovest.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.